Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups

Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups

Abstract Background Medulloblastoma (MB) is a heterogeneous disease, displaying distinct genetic profiles with specific molecular subgroups. This study aimed to validate MB molecular subgrouping using surrogate immunohistochemistry and associate molecular subgroups, histopathological types, and avai...

Full description

Bibliographic Details
Main Authors: Asmaa Mustafa Eid, Nehal Abd El-Ghaffar Heabah
Format: Article
Language:English
Published: SpringerOpen 2021-02-01
Series:Journal of the Egyptian National Cancer Institute
Subjects:
Medulloblastoma
Molecular classification
β-catenin
GAB1
Histological types
Risk stratification
Online Access:https://doi.org/10.1186/s43046-021-00060-w

Internet

https://doi.org/10.1186/s43046-021-00060-w

Similar Items